Safety and immunogenicity of the quadrivalent HPV vaccine in female Systemic Lupus Erythematosus patients aged 12 to 26 years

BACKGROUND: Women with SLE have higher rates of persistent human papilloma virus (HPV) infections and precancerous lesions than healthy women. HPV vaccine is safe and effective in healthy females aged 9–26 years. There are limited data on the safety and immunogenicity of HPV vaccine in females with...

Full description

Saved in:
Bibliographic Details
Main Authors: Soybilgic, Arzu, Onel, Karen B, Utset, Tammy, Alexander, Kenneth, Wagner-Weiner, Linda
Format: Artigo
Language:Inglês
Published: BioMed Central 2013
Subjects:
Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3751269/
https://ncbi.nlm.nih.gov/pubmed/23924237
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1546-0096-11-29
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items